Sanofi said Friday that it plans to separate its consumer health division into a stand-alone company next year, turning the ...

Sanofi says the deal announced today will make it the world's number one consumer health company, with expected revenues of around €5.1 billion in 2015 ($5.61 billion) and a global market share ...

Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at ...

Sanofi is following in the footsteps of a number of its peers in pharma with a plan to spin off its consumer health business into a separate company and focus its efforts on its prescription drugs ...

Sanofi's stock has shown volatility, but recent gains are driven by Dupixent's success, the Consumer Health spin-out, and promising pipeline assets. Despite a Q323 earnings miss and downbeat ...

Buyout firm PAI Partners is seeking to rope in two of the world’s largest sovereign wealth funds to back its offer for French drugmaker Sanofi SA’s consumer health division, according to ...

Clayton Dubilier & Rice is discussing the possibility of using borrowed money to fund a part of the equity check in its bid ...

What's Sanofi Consumer Healthcare India Ltd share price today. Get Sanofi Consumer Healthcare India Ltd latest news on BSE/NSE stock price live updates, Sanofi Consumer Healthcare India Ltd financial ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

FRANKFURT (Reuters) - Sanofi said on Friday that its multiple sclerosis drug candidate was shown to delay worsening of a ...

Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...

Sanofi Consumer Healthcare India Limited (SCHIL) is successfully listed on BSE Limited (BSE) and National Stock Exchange of India Limited (NSE). The milestone was marked with the ringing of the ...